Stage FocusSeed, Series A
GeographyUS
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedtech
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Cure Ventures is a life sciences venture capital firm founded in 2021, built around forming new companies from the ground up rather than backing existing teams. It closed its inaugural fund at $350 million and invests through a seed funding model designed to de-risk the underlying science before a company scales, with genetic validation used to increase the odds of clinical success and Cure's own ...
Notable Investments
X
XenImmuneT
Tasca TherapeuticsSimilar Funds
3B
3E Bioventures Capital
China
Pure DeepTechBiotechMedtechSeedSeries A
AL
Advent Life Sciences
London, United Kingdom
Pure DeepTechBiotechMedtechSeedSeries A
AV
Alix Ventures
San Francisco, United States
Pure DeepTechBiotechSynthetic BiologyMedtechPre-SeedSeed
ARCH Venture Partners
Chicago, United States
Pure DeepTechBiotechMedtechSynthetic BiologySeedSeries A
Atlas Venture
Cambridge, United States
Pure DeepTechBiotechSynthetic BiologyMedtechSeedSeries A
Bold Capital Partners
Santa Monica, United States
Pure DeepTechBiotechAIMedtechSeedSeries A